Membrane domain modulation of Aβ1-42 oligomer interactions with supported lipid bilayers: an atomic force microscopy

Mehdi Azouz1, Christophe Cullin2, Sophie Lecomte2

  • 1Chimie et Biologie des Membranes et Nanoobjets, CBMN CNRS UMR 5248, Université de Bordeaux, Allée Geoffroy de Saint-Hilaire, 33600 Pessac, France and Department of Chemistry, Université de Montréal, Montréal, Québec, Canada. Michel.lafleur@umontreal.ca.

Nanoscale
|October 29, 2019
PubMed

Insights

Alzheimer's disease involves amyloid peptide Aβ1-42 damaging lipid membranes. This study shows lipid domains promote this damage, with specific lipid compositions exacerbating membrane fragmentation and peptide aggregation.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Materials Science

Background:

  • Alzheimer's disease (AD) is a growing neurodegenerative concern linked to amyloid peptide Aβ1-42.
  • Aβ1-42 interacts with lipid membranes, potentially causing damage and fragmentation.
  • Membrane composition, particularly lipid domains (rafts), may influence these interactions.

Purpose of the Study:

  • To investigate how lipid segregation and domain formation affect the membrane-perturbing activity of Aβ1-42.
  • To compare the effects of Aβ1-42 with an oligomeric mutant (G37C) on lipid bilayers.
  • To understand the role of cholesterol and ganglioside GM1 in Aβ peptide-induced membrane damage.

Main Methods:

  • Utilized Atomic Force Microscopy (AFM) to visualize peptide interactions with supported lipid bilayers.
  • Examined ternary lipid mixtures (DOPC/DPPC/cholesterol and DOPC/sphingomyelin/cholesterol) exhibiting liquid-liquid phase separation.
  • Studied model 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes with added cholesterol or ganglioside GM1.

Main Results:

  • Aβ1-42 and G37C peptides preferentially aggregated on liquid-disordered domains in ternary mixtures, causing deposits and membrane fragmentation.
  • Cholesterol and GM1 (at 10 mol%) in POPC membranes promoted Aβ1-42 and G37C association, leading to significant membrane fragmentation.
  • AFM confirmed that lipid domains enhance membrane perturbations by amyloid peptides.

Conclusions:

  • Lipid domains act as nucleation sites for amyloid peptides, facilitating membrane damage.
  • The G37C mutant induced more severe bilayer perturbations than Aβ1-42, suggesting toxicity of non-fibrillar oligomers.
  • Understanding these peptide-lipid interactions is crucial for developing Alzheimer's disease therapies.